XML 55 R43.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity - Other (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Nov. 30, 2022
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
May 31, 2024
Jan. 01, 2024
Stockholders' Equity              
Total compensation cost   $ 4,917 $ 3,891 $ 10,110 $ 7,632    
Maximum percentage of beneficial ownership for exercise of Pre-funded Warrants 9.99%            
Maximum percentage increase or decrease of beneficial ownership for exercise of Pre-funded Warrants 19.99%            
Public Offering.              
Stockholders' Equity              
Number of shares of common stock issued 12,421,053            
Proceeds from Issuance or Sale of Equity $ 64,500            
Number of pre-funded warrants (in shares) 2,105,264            
Research and development.              
Stockholders' Equity              
Total compensation cost   1,444 1,468 3,276 2,810    
Selling, general and administrative              
Stockholders' Equity              
Total compensation cost   3,143 $ 2,423 6,504 $ 4,822    
Restructuring Charges              
Stockholders' Equity              
Total compensation cost   $ 330   $ 330      
Series A Convertible Preferred Stock              
Shares              
Conversion of Series A Convertible Preferred Stock (in shares)   0 0 0      
Preferred stock, shares outstanding   0 4,300 0 4,300    
Number of common shares issuable upon conversion of stock     860,000   860,000    
Employee Stock Option              
Stock Options              
Outstanding (in shares)   8,859,400   8,859,400      
Outstanding, weighted-average exercise price (in dollars per share)   $ 9.08   $ 9.08      
Granted (in shares)       2,391,211      
Granted (in dollars per share)       $ 7.20      
Restricted Stock Units              
Stockholders' Equity              
Vesting period       3 years      
Shares              
Issued (in shares)       1,920,135      
Awards outstanding (in shares)   2,449,334   2,449,334      
2014 Plan              
Stockholders' Equity              
Common stock reserved for issuance (in shares)   0   0     3,090,220
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant             0
2014 Plan | Employee Stock Option              
Stock Options              
Outstanding (in shares)   6,160,958   6,160,958      
Granted (in shares)       1,540,519      
Equity Incentive Plan, Employee Inducements | Employee Stock Option              
Stock Options              
Outstanding (in shares)   1,971,725   1,971,725      
Granted (in shares)       123,975      
2024 Plan              
Stockholders' Equity              
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant   3,532,098   3,532,098      
Stock Options              
Outstanding (in shares)   726,717   726,717      
2024 Plan | Maximum              
Stockholders' Equity              
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized           4,000,000  
2024 Plan | Employee Stock Option              
Stock Options              
Granted (in shares)       726,717